Global Pharma Leaders to Gather in Islamabad for PPMA Summit on September 24

Islamabad is set to host a landmark gathering of international pharmaceutical leaders as the Pakistan Pharmaceutical Manufacturers’ Association (PPMA) prepares for its 8th Pharma Summit on September 24. Themed “The Future of Pharma: AI Integration for Enhanced Drug Discovery and Personalised Medicine,” the summit will spotlight innovation, exports, and regulatory transformation in Pakistan’s pharma sector.

A Platform for Global Collaboration and Investment

The summit will bring together top executives, researchers, and policymakers from around the world to explore emerging trends in drug development, manufacturing, and healthcare delivery. Discussions will focus on artificial intelligence (AI), personalized medicine, and strategies to boost Pakistan’s pharmaceutical exports.

PPMA’s Vision for a Modernized Pharma Ecosystem

PPMA Chairman Tauqeer Ul Haq emphasized that the summit aims to position Pakistan as a competitive player in the global pharmaceutical landscape. He highlighted the importance of AI in revolutionizing drug discovery, improving patient outcomes, and enhancing operational efficiency across the industry.

Key Themes and Strategic Goals

  • Integration of AI in clinical research and diagnostics
  • Expansion of Pakistan’s pharmaceutical export footprint
  • Strengthening regulatory frameworks and DRAP compliance
  • Encouraging foreign investment and joint ventures
  • Promoting innovation in drug safety and personalized therapies

A Milestone for Pakistan’s Pharma Industry

The summit is expected to catalyze new partnerships, policy reforms, and technological adoption. It reflects Pakistan’s commitment to transforming its healthcare and pharmaceutical sectors through global collaboration and cutting-edge innovation.